Xenia Hotels & Resorts (XHR) Earnings Analysis
Xenia Hotels & Resorts (XHR) next reports earnings on 2026-07-30, consensus EPS 0.245 USD. Last quarter (2026-05-01) it beat with EPS 0.21 USD vs 0.18 USD est (+16.7%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 31.56.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does XHR next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.245 USD |
| Revenue estimate | 0.30B |
XHR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-01 | 0.21 USD | 0.18 USD | +16.7% | Beat |
| 2025-10-31 | 0.23 USD | 0.035 USD | +557.1% | Beat |
| 2025-08-01 | 0.57 USD | 0.43 USD | +32.6% | Beat |
| 2025-05-02 | 0.51 USD | 0.42 USD | +21.4% | Beat |
| 2024-08-01 | 0.52 USD | 0.49 USD | +6.1% | Beat |
Beat rate: 5/5 (100%) over reported quarters with consensus data.
XHR valuation and analyst view
| Trailing P/E | 31.56 |
|---|---|
| Trailing EPS | 0.72977 USD |
| Price / book | 1.72 |
| Dividend yield | 2.63% |
| Market cap | 1.97B |
| Analyst consensus | Hold (4 buy / 5 hold / 1 sell) |
| Avg price target | 20.75 USD |
Related research pages
Frequently asked questions
When is Xenia Hotels & Resorts (XHR)'s next earnings date?
Xenia Hotels & Resorts is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.245 USD and revenue estimate of 0.30B.
Did XHR beat earnings last quarter?
In its 2026-05-01 report, XHR posted EPS of 0.21 USD versus a 0.18 USD estimate — a beat of 16.7%.
What is XHR's earnings track record?
Over the last 5 reported quarters with consensus data, XHR beat estimates 5 times (100%).
What is XHR's current P/E ratio and EPS?
XHR trades at a trailing P/E of 31.56 on trailing EPS of 0.7297724464635749 USD.
What do analysts rate XHR?
Analyst consensus is "Hold" across 10 ratings (0 strong buy, 4 buy, 5 hold, 1 sell, 0 strong sell). Average 12-month price target: 20.75 USD.